Peer Review History
| Original SubmissionMay 1, 2025 |
|---|
|
PCOMPBIOL-D-25-00867 Memorization Bias Impacts Modeling of Alternative Conformational States of Solute Carrier Membrane Proteins with Methods from Deep Learning PLOS Computational Biology Dear Dr. Montelione, Thank you for submitting your manuscript to PLOS Computational Biology. After careful consideration, we feel that it has merit but does not fully meet PLOS Computational Biology's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript within 30 days Sep 05 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at ploscompbiol@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pcompbiol/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: * A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to formatting updates and technical items listed in the 'Journal Requirements' section below. * A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'. * An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'. If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. We look forward to receiving your revised manuscript. Kind regards, Alex Peralvarez-Marin Academic Editor PLOS Computational Biology Arne Elofsson Section Editor PLOS Computational Biology Journal Requirements: 1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full. At this stage, the following Authors/Authors require contributions: Gaetano Montelione. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form. The list of CRediT author contributions may be found here: https://journals.plos.org/ploscompbiol/s/authorship#loc-author-contributions 2) We ask that a manuscript source file is provided at Revision. Please upload your manuscript file as a .doc, .docx, .rtf or .tex. If you are providing a .tex file, please upload it under the item type u2018LaTeX Source Fileu2019 and leave your .pdf version as the item type u2018Manuscriptu2019. 3) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines: https://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-parts-of-a-submission 4) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: https://journals.plos.org/ploscompbiol/s/figures 5) We notice that your supplementary Figures, and Tables are included in the manuscript file. Please remove them and upload them with the file type 'Supporting Information'. Please ensure that each Supporting Information file has a legend listed in the manuscript after the references list. 6) Please amend your detailed Financial Disclosure statement. This is published with the article. It must therefore be completed in full sentences and contain the exact wording you wish to be published. 1) State what role the funders took in the study. If the funders had no role in your study, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." 2) If any authors received a salary from any of your funders, please state which authors and which funders. 7) Please provide a completed 'Competing Interests' statement, including any COIs declared by your co-authors. If you have no competing interests to declare, please state "The authors have declared that no competing interests exist". Otherwise please declare all competing interests beginning with the statement "I have read the journal's policy and the authors of this manuscript have the following competing interests:" Reviewers' comments: Reviewer's Responses to Questions Reviewer #1: Swapna et al. used a template-based ESM modelling approach to obtain the alternate conformational states of SLC proteins. The authors also compared several ML based approaches such as AF2, AF3, ESM; highlighting the current limitations of these ML methods in modeling multiple conformational states of SLC proteins. The obtained structures were validated by using the EC data. The authors claimed to validate these structures using EC data as “experimental validation”, which I find surprising. Perhaps “validation” is more appropriate than “experimental validation”. The authors also highlighted the limitation of their high performing ESM-AF2 approach in modelling SLC proteins alternate states in several scenarios. The manuscript is well written and will be useful for researchers working on transmembrane proteins with multiple conformational states. Minor points: Page 13, line 3: “is it” should be “it is” Page 13, 3rd paragraph: “Lazou al” should be “Lazou et al.” Page 25, Fig. S3: The green and red circles seem to be flipped. Reviewer #2: Though AlphaFold has revolutionized protein structure prediction, it has limitations. Here, Swapna and colleagues show one of its limitations–and some workarounds–when modeling alternative conformations of SLC Membrane proteins. The observations and approaches presented are useful, and I applaud the authors’ use of ECs to check the plausibility of the alternative conformations they generate. This work is solid and suitable for publication after a few minor concerns are addressed: 1) On Page 10, it is claimed that AF3 does not support template-directed modeling. What does this mean? AF3 uses templates in default mode, and it seems the input files could be modified to include templates of interest. 2) On Page 5, it says that AlphaFold-alt was run generating 30 conformations for sequence depths ranging from 16-32. Was it also run to generate MSAs with 4-8 sequences specified in Table S1? The Methods could be more clear on this point. 3) Faezov and Dunbrack also used templates to bias AlphaFold2 to generate models of alternative conformations of protein kinases (https://www.biorxiv.org/content/10.1101/2023.07.21.550125v2). Although they used a somewhat different approach than presented here, their work should be cited. 4) The manuscript seems to suggest that memorization occurs only when structures with the exact sequence being tested were in the database prior to training. This may be too narrow of a definition. AlphaFold can associate memorized structures with homologous sequences without evolutionary couplings (Chakravarty, et al. 2024). This is likely why, when CFold was trained (Bryant and Noé, 2024), all homologous alternative conformations were excluded from the training data. If one alternative structure is present in the training data, AF may associate its memorized structure with a homologous sequence without coevolutionary inference. Reviewer #3: This is a very interesting article providing not only quantitative insights into the limitations of machine-learning methods in structure prediction of dynamic proteins, but also providing a robust, consistent strategy to predict alternate states for membrane proteins with inverted topologies. These proteins have repeats within their sequences, that the authors reverse and feed into ESMfold to create a template with alternate conformation that can then be used for template-based modeling of the alternate state. This is a creative extension of the method that I and others have developed in the past, while avoiding the pitfalls of repeat-based sequence alignments and also leveraging the high-quality models that are created by machine learning methods. The paper is generally clearly written and should be of value for the structure prediction community, especially since the scripts are publicly available. I only have a few comments for the author's consideration: - I wonder if "virtual flipped sequence" could/should be rephrased for clarity, perhaps "artificial" or "constructed" or "reordered" would be better terms. Essentially the repeated elements are swapped to create the new sequence. - I could not find mention of how the sequence repeats are identified so that they can be swapped: Where one structure is known, the repeat definitions identified by symmetry analysis could be used, e.g. from the Encompass database. - An desirable extension of the method would (eventually) be to create complete conformational landscapes beyond the three major "inward-open", "occluded", "outward-open" states. This should be mentioned in the discussion. Based on the ideas of del Alamo et al, we have recently been successful in applying AF2.3 with sequence-downsampling to create an extensive ensemble for a heterodimeric mitochondrial pyruvate carrier, as an example (PMID: 40249800). Could perhaps providing two templates as simultaneous inputs allow ESMfold to explore all those states? - Several figures rely on red and green for comparisons; colorblind-friendly alternatives should be created ********** Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #2: No Reviewer #3: Yes: Lucy Rachel Forrest [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] Figure resubmission: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions. Reproducibility: To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols |
| Revision 1 |
|
Dear Prof Montelione, We are pleased to inform you that your manuscript 'Memorization Bias Impacts Modeling of Alternative Conformational States of Solute Carrier Membrane Proteins with Methods from Deep Learning' has been provisionally accepted for publication in PLOS Computational Biology. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. Best regards, Alex Peralvarez-Marin Academic Editor PLOS Computational Biology Arne Elofsson Section Editor PLOS Computational Biology *********************************************************** Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The authors addressed all the points. Reviewer #3: The authors have addressed all my comments. I tank them for thoroughly considering the issue of color blind readers. ********** Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: None Reviewer #3: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy . Reviewer #1: No Reviewer #3: Yes: Lucy R. Forrest |
| Formally Accepted |
|
PCOMPBIOL-D-25-00867R1 Memorization Bias Impacts Modeling of Alternative Conformational States of Solute Carrier Membrane Proteins with Methods from Deep Learning Dear Dr Montelione, I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. For Research, Software, and Methods articles, you will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! With kind regards, Aiswarya Satheesan PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .